Edition:
United Kingdom

Amyris Inc (AMRS.OQ)

AMRS.OQ on NASDAQ Stock Exchange Global Select Market

4.96USD
15 Feb 2019
Change (% chg)

-- (--)
Prev Close
$4.96
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
504,018
52-wk High
$9.28
52-wk Low
$2.64

Latest Key Developments (Source: Significant Developments)

Amyris Announces $255 Mln Cannabinoid Development, Licensing & Commercialization Agreement
Tuesday, 5 Feb 2019 

Feb 5 (Reuters) - Amyris Inc ::AMYRIS ANNOUNCES $255 MILLION CANNABINOID DEVELOPMENT, LICENSING AND COMMERCIALIZATION AGREEMENT − REPRESENTS LARGEST COLLABORATION AGREEMENT TO DATE FOR AMYRIS.AMYRIS INC - $255 MILLION IN PAYMENTS INCLUDE AN UPFRONT PAYMENT.AMYRIS INC - REMAINDER OF PAYMENTS LINKED TO MILESTONES THAT ARE EXPECTED OVER NEXT 12-36 MONTHS FOLLOWING SIGNING OF A DEFINITIVE FINAL AGREEMENT.AMYRIS - DEVELOPMENT TO BEGIN IMMEDIATELY & COMMERCIALIZATION OF PRODUCTS EXPECTED WITHIN NEXT 18-24 MONTHS ASSUMING APPROPRIATE REGULATORY APPROVALS.AMYRIS INC - PARTNER WILL BE GRANTED A LICENSE TO COMMERCIALIZE PRODUCTS.AMYRIS INC - "AMYRIS WILL BE ELIGIBLE TO RECEIVE SUBSTANTIAL ONGOING ROYALTY PAYMENTS" FROM DEAL.AMYRIS INC - COMMITTED TO EXECUTING FINAL DEFINITIVE AGREEMENT BY END OF MARCH.  Full Article

Amyris Files Prospectus Relating To Registration For Potential Offer, Sale Of Up To 19.5 Million Shares Of Common Stock By Selling Stockholders
Tuesday, 8 Jan 2019 

Jan 8 (Reuters) - Amyris Inc ::AMYRIS - FILES PROSPECTUS RELATING TO REGISTRATION FOR POTENTIAL OFFER, SALE OF UP TO 19.5 MILLION SHARES OF COMMON STOCK BY SELLING STOCKHOLDERS.  Full Article

Amyris Announces Signing Of Nutritional Product Royalty Agreement
Monday, 31 Dec 2018 

Dec 31 (Reuters) - Amyris Inc ::AMYRIS ANNOUNCES SIGNING OF NUTRITIONAL PRODUCT ROYALTY AGREEMENT.AMYRIS INC - SIGNED A LONG-TERM AGREEMENT WITH XINFU OF CHINA FOR A SIGNIFICANT INITIAL PAYMENT AND A LONG-TERM MINIMUM ANNUAL SHARE.AMYRIS INC - AGREEMENT WITH XINFU OF CHINA FOR LONG-TERM MINIMUM ANNUAL SHARE OF AN EXISTING NUTRITIONAL PRODUCT ROYALTY ARRANGEMENT.AMYRIS INC - AGREEMENT INCLUDES MATERIAL UPFRONT PAYMENT EQUAL TO $50 MILLION EXPECTATION SET BY CO DURING Q3 EARNINGS CALL.  Full Article

Amyris Sells $60 Mln Unsecured Convertible Senior Notes
Friday, 7 Dec 2018 

Dec 7 (Reuters) - Amyris Inc ::HAS ENTERED INTO DEFINITIVE AGREEMENTS FOR SALE OF $60 MILLION OF UNSECURED CONVERTIBLE SENIOR NOTES.NOTES WILL MATURE IN DECEMBER 2021..ENTERED AGREEMENTS FOR SALE OF $60 MILLION OF UNSECURED CONVERTIBLE SENIOR NOTES IN A PRIVATE PLACEMENT WITH 2 "ACCREDITED INVESTORS".INITIAL CONVERSION PRICE FOR NOTES WILL BE $6.32.INTENDS TO USE NET PROCEEDS FROM PLACEMENT TOGETHER TO PARTLY REPAY COMPANY'S OUTSTANDING 6.5% AND 9.5% CONVERTIBLE NOTES DUE IN 2019.NOTES WILL AMORTIZE IN EQUAL MONTHLY PAYMENTS STARTING ON APRIL 1, 2019..  Full Article

Amyris Signs Supply And Distribution Pact With ASR Group
Wednesday, 3 Oct 2018 

Oct 3 (Reuters) - Amyris Inc ::AMYRIS INC - IT HAS SIGNED ITS FIRST SUPPLY AND DISTRIBUTION AGREEMENT FOR ITS NEW, SUGARCANE-DERIVED, ZERO CALORIE SWEETENER WITH ASR GROUP.  Full Article

Amyris Enters Collaboration Agreement With Yifan Pharma
Thursday, 27 Sep 2018 

Sept 27 (Reuters) - Amyris Inc ::AMYRIS ENTERS INTO EXTENSIVE COLLABORATION AGREEMENT WITH LEADING CHINESE PHARMACEUTICAL COMPANY, YIFAN PHARMACEUTICAL CO., LTD..AMYRIS INC - ENTERED INTO A MULTI-YEAR, MULTI-MILLION-DOLLAR AGREEMENT WITH A UNIT OF YIFAN PHARMACEUTICAL CO LTD.AMYRIS INC - COLLABORATION IS STARTING WITH FIRST TARGET IN NUTRITION FOR A KEY MOLECULE TO BE DEVELOPED, SCALED AND MANUFACTURED BY AMYRIS.AMYRIS INC - COMPANIES EXPECT TO BRING TO MARKET 3-5 ADDITIONAL PRODUCTS IN COMING YEARS.AMYRIS INC - UPON SUCCESSFUL COMMERCIALIZATION, CO EXPECTS TO DEVELOP THIS LINE OF BUSINESS INTO $100 MILLION OR MORE OF EXPECTED ANNUAL REVENUE.AMYRIS - EXPECTS PRODUCT BEING COMMERCIALIZED WITHIN CHINESE MARKET AND REST OF GLOBAL MARKET BY 2021 WITH FIRST PRODUCT REVENUE ACHIEVED SAME YEAR.  Full Article

Amyris Files For Potential Sale Of 3.6 Mln Shares By Selling Stockholders
Wednesday, 26 Sep 2018 

Sept 26 (Reuters) - Amyris Inc ::AMYRIS FILES FOR POTENTIAL SALE OF 3.6 MILLION COMMON SHARES BY SELLING STOCKHOLDERS - SEC FILING.  Full Article

Amyris Gets Green Light For Commercial Sales Of New Sweetener
Thursday, 30 Aug 2018 

Aug 30 (Reuters) - Amyris Inc ::AMYRIS GETS GREEN LIGHT FOR COMMERCIAL SALES OF ITS NEW, NATURAL, ZERO-CALORIE SWEETENER.  Full Article

Amyris Announces Secondary Offering Of 7.65 Mln Shares Priced At $6.25 Per Share
Friday, 17 Aug 2018 

Aug 17 (Reuters) - Amyris Inc ::AMYRIS ANNOUNCES PRICING OF SECONDARY OFFERING.SAYS SECONDARY OFFERING OF 7.65 MILLION SHARES PRICED AT $6.25PER SHARE.AMYRIS ANNOUNCES PRICING OF SECONDARY OFFERING.  Full Article

Amyris Announces Non-Dilutive $36 Mln Term Loan
Monday, 2 Jul 2018 

July 2 (Reuters) - Amyris Inc ::AMYRIS ANNOUNCES NON-DILUTIVE $36 MILLION TERM LOAN TO PAY OFF STEGODON AND OTHER SHORT-TERM DEBT MATURITIES.AMYRIS INC - CASH FROM TERM LOAN WILL BE USED TO PAY OFF COMPANY'S STEGODON AND OTHER SHORT-TERM DEBT MATURITIES.AMYRIS INC - TERM LOAN ALSO INCLUDES ADDITIONAL $35 MILLION ACCORDION CREDIT FACILITY WITH OPTION FOR FINANCING CONSTRUCTION OF PRODUCTION FACILITY.  Full Article